What is GMED's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 10.30B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for GMED?

P/E (TTM) is 19.77 and 52-week range is $56.96 to $101.40 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s GMED figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for GMED?

The company profile lists revenue (TTM) near $3.11B, net income (TTM) near $529M, EPS (TTM) near $3.91 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Globus Medical Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Audubon, Pennsylvania, US, 135.7M shares outstanding, ISIN US3795772082 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

Globus Medical Inc

$GMED

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$76.71

-2.70%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.

Employees

6,000

Website

www.globusmedical.com/

IPO

2012-03-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)